Ovarian

Ongoing 06 Oct 2026

MEN2501-01

A Phase 1, First-in-Human Study of MEN2501, a KIF18A Inhibitor, in Participants with platinum-resistant Ovarian Cancer.

Enquire

Trial overview

Clinical Area

Medical Oncology

Disease

Ovarian

Disease site

Gynaecology

Study Phase

Trial Identifiers

Registration number: NCT07226427

https://clinicaltrials.gov/study/NCT07226427

GenesisCare Location(s)

Campbelltown

38 Camden Road, Campbelltown, NSW, 2560, Australia

(02) 4632 5500

admin.campbelltown@genesiscare.com

Find out more Get directions

Principal Investigator(s)

Medical Oncologist

Dr Felicia Roncolato

MBChB FRACP MMed (Clin Epi) PhD

View Profile

Clinical trials enquiries

Thank you for submitting.

We will be in touch within 24 hours

Form submission error

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.

First name *

Last name *

Email *

Phone *

+61

Postalcode *

State/territory *

What is the reason for enquiry?

How would you prefer to be contacted? *

Phone Email

By clicking “submit” below, you acknowledge we will use the information you are providing to contact you about your referral request. Refer to our Private Policy for more information about how we handle personal information.

Disclaimer:

Safe, secure use of AI-assisted clinical notes. Always with your consent

Doctors use Heidi AI during your consult to record and transcribe medically relevant information for their clinical notes and correspondence.

Your doctor will always ask before using Heidi AI. You can decline or withdraw consent anytime. All data is locally hosted in Australia. No recordings are ever stored. https://www.heidihealth.com/

Disclaimer:

This website is provided for information purposes only. Nothing on this website is intended to be used as medical advice, or to diagnose, treat, cure or prevent any disease. It should not be used as a substitute for your own health professional's advice. Any medical procedure or treatment carries risks. Before proceeding with treatment, you should discuss the risks and benefits of the treatment with an appropriately qualified health practitioner. Individual treatment outcomes and experiences will vary.

MEN2501-01

Trial overview

Campbelltown

Medical Oncologist

Dr Felicia Roncolato

Clinical trials enquiries

Thank you for submitting.

An unexpected error has occurred.

How can we help?

Who we are

Website policies

Your local GenesisCare

Contact us

MEN2501-01

Trial overview

Campbelltown

Medical Oncologist

Dr Felicia Roncolato

Clinical trials enquiries

Thank you for submitting.

An unexpected error has occurred.

How can we help?

Please refer to your hospitals process for inpatient referrals...

Who we are

Website policies

Your local GenesisCare

Contact us

You are leaving our website